スプートニクV COVID-19ワクチン
脚注・出典

1 2 3 4 5  “Sputnik V”. Russian drug reference.   Medum.ru. 2021年2月26日閲覧。
1 2 3 4 5 6 7  Callaway E (August 2020). “Russia's fast-track coronavirus vaccine draws outrage over safety”. Nature 584 (7821):  334–335. doi:10.1038/d41586-020-02386-2. PMID 32782400. https://www.nature.com/articles/d41586-020-02386-2. "This is a reckless and foolish decision. Mass vaccination with an improperly tested vaccine is unethical. Any problem with the Russian vaccination campaign would be disastrous both through its negative effects on health, but also because it would further set back the acceptance of vaccines in the population."
1 2 3 4 5 6  Cohen J (11 August 2020). “Russia's approval of a COVID-19 vaccine is less than meets the press release”. Science. https://www.sciencemag.org/news/2020/08/russia-s-approval-covid-19-vaccine-less-meets-press-release 13 August 2020閲覧。
1 2  Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, Botikov AG (2021-02-02). “Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia”. The Lancet. doi:10.1016/s0140-6736(21)00234-8. PMC 7852454. PMID 33545094. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852454/.
↑  “Глава РФПИ объяснил значение буквы "V" в названии "Спутника V"” (ロシア語). РИА Новости (2020年12月24日). 2021年5月28日閲覧。
1 2 3 4  Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, Grousova DM, Erokhova AS, Kovyrshina AV, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Lubenets NL, Egorova DA, Shmarov MM, Nikitenko NA, Morozova LF, Smolyarchuk EA, Kryukov EV, Babira VF, Borisevich SV, Naroditsky BS, Gintsburg AL (September 2020). “Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia”. Lancet 396 (10255):  887–897. doi:10.1016/S0140-6736(20)31866-3. PMC 7471804. PMID 32896291. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471804/.
↑  Mahase E (August 2020). “Covid-19: Russia approves vaccine without large scale testing or published results”. BMJ 370:  m3205. doi:10.1136/bmj.m3205. PMID 32816758.
1 2 3 4 5  Burki TK (November 2020). “The Russian vaccine for COVID-19”. The Lancet. Respiratory Medicine 8 (11):  e85–e86. doi:10.1016/S2213-2600(20)30402-1. PMC 7837053. PMID 32896274. https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30402-1/fulltext.
1 2 3  Berkeley Jr L (11 August 2020). “Scientists worry whether Russia's Sputnik V' coronavirus vaccine is safe and effective” (英語). CNBC. https://www.cnbc.com/2020/08/11/scientists-worry-whether-russias-sputnik-v-coronavirus-vaccine-is-safe-and-effective.html 11 August 2020閲覧。
1 2  “Sputnik V authorized in Myanmar” (英語). sputnikvaccine.com. 2021年2月9日閲覧。
↑  Kramer, Andrew. “Russia is offering to export hundreds of millions of vaccine doses, but can it deliver?”. nytimes.com. 20 February 2021閲覧。
1 2  「露ワクチン 供給遅れ／生産拠点不 足外交戦略ほころび」『読売新聞』朝刊2021年7月31日（国際面）
↑  Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, Grousova DM, Erokhova AS, Kovyrshina AV, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Lubenets NL, Egorova DA, Shmarov MM, Nikitenko NA, Morozova LF, Smolyarchuk EA, Kryukov EV, Babira VF, Borisevich SV, Naroditsky BS, Gintsburg AL (September 2020). “Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia”. Lancet 396 (10255):  887–897. doi:10.1016/S0140-6736(20)31866-3. PMC 7471804. PMID 32896291. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471804/.
1 2  “An Open Study of the Safety, Tolerability and Immunogenicity of the Drug 'Gam-COVID-Vac' Vaccine Against COVID-19”.   ClinicalTrials.gov (22 June 2020). 2020年2月26日閲覧。
↑  “Coronavirus Vaccine Trials Advance in Race for Covid-19 Protection” (英語).  Bloomberg. 2020年8月10日閲覧。
↑  “Russia's RDIF & Prominent Government Lab Progress COVID-19 Vaccine: Production Facility Readied in the Moscow Region” (英語). trialsitenews.com (June 10, 2020). 2020年8月11日閲覧。
↑  Sokolov A (December 12, 2020). “Сколько хотят заработать на прививках от коронавируса”. Vedomosti.  オリジナルの2020-08-12時点におけるアーカイブ。. https://web.archive.org/web/20200812144536/https://www.vedomosti.ru/business/articles/2020/08/11/836418-sputnik-koronavirusom 2020年12月20日閲覧。.
↑  “Нормативная документация ЛП-006395-110820” (ロシア語).   Russian Ministry of Health (2020年). 2020年9月21日閲覧。
↑  “Центр Гамалеи назвал сроки вакцинации большей части населения России”.   RBK (September 4, 2020). 2020年9月6日閲覧。
↑  Sagdiev R, Ivanova P, Nikolskaya P, Swift R, Smout A (17 November 2020). “Russia focuses on freeze-dried vaccine doses as transport fix”. Reuters (Moscow). https://www.reuters.com/article/health-coronavirus-russia-vaccine-transp/rpt-exclusive-russia-focuses-on-freeze-dried-vaccine-doses-as-transport-fix-idUSL1N2I30ML 20 November 2020閲覧。
↑  Ellyatt H (2020年9月10日). “Scientists question 'strange' data in Russian coronavirus vaccine trial after 'unlikely' patterns”. CNBC. https://www.cnbc.com/2020/09/10/scientists-question-russian-vaccine-trial-data-on-unlikely-patterns.html 2020年9月10日閲覧。
↑  Logunov DY, Dolzhikova IV, Tukhvatullin AI, Shcheblyakov DV (October 2020). “Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors' reply”. Lancet 396 (10256):  e54–e55. doi:10.1016/S0140-6736(20)31970-X. PMC 7503057. PMID 32971043. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31970-X/fulltext.
↑  “Hadassah bringing 1.5 million doses of Russian COVID-19 vaccine to Israel” (英語). The Jerusalem Post | JPost.com. 2020年11月19日閲覧。
↑  “Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19” (英語).   National Library of Medicine. 28 September 2020閲覧。
↑  “Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus” (英語). clinicaltrials.gov. 2021年1月14日閲覧。
↑  “UAE volunteers receive Russian Covid-19 vaccine”. Khaleej Times. (January 10, 2021). https://www.khaleejtimes.com/coronavirus-pandemic/video-uae-volunteers-receive-russian-covid-19-vaccine
↑  Bharadwaj S (January 15, 2021). “Dr Reddy's gets DCGI nod for Covid-19 vaccine Sputnik V Phase III trials”. The Times Of India. https://timesofindia.indiatimes.com/business/india-business/dr-reddys-gets-dcgi-nod-for-covid-19-vaccine-sputnik-v-phase-iii-trials/articleshow/80291011.cms
↑  臨床試験番号 NCT04642339 研究名 "Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela" - ClinicalTrials.gov
↑  Logunov, Denis (2021-02-02). “Sputnik V COVID-19 vaccine candidate appears safe and effective”. The Lancet. doi:10.1016/S0140-6736(21)00234-8. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/fulltext.
↑  The Guardian: Sputnik V vaccine has 91.6% efficacy against symptomatic Covid, Russian trial suggests
↑  “RDIF, The Gamaleya National Center, AstraZeneca and R-Pharm sign an agreement to cooperate on COVID-19 vaccine development”. The Russian Direct Investment Fund (21 December 2020). 2020年2月26日閲覧。
↑  “Azerbaijan allowed for the first in the world to study a combination of "Sputnik V" vaccine and COVID-19 vaccine developed by "AstraZeneca" Company”.   MoH of Azerbaijan (9 February 2021). 2020年2月26日閲覧。
↑  “Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, Given in Combination With rAd26-S, Recombinant Adenovirus Type 26 Component of Gam-COVID-Vac Vaccine, for the Prevention of COVID-19”. ClinicalTrials.gov.   U.S. National Library of Medicine (14 January 2021). 9 February 2021閲覧。
↑  “В России зарегистрировали вакцину «Спутник Лайт»” (ロシア語). РБК. 2021年5月7日閲覧。
↑  “Russia Approves Single-Dose Sputnik Light Covid Vaccine For Use”. NDTV Coronavirus. (6 May 2021). https://www.ndtv.com/world-news/russia-approves-single-dose-sputnik-light-covid-19-vaccine-for-use-2436470
↑  “An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine”. clinicaltrials.gov. 2021年7月21日閲覧。
↑  “Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light (SPUTNIK-LIGHT)”. clinicaltrials.gov. 2021年7月21日閲覧。
↑  "Single dose vaccine, Sputnik Light, authorized for use in Russia" (Press release). Russian Direct Investment Fund. 6 May 2021. 2021年5月7日閲覧。
↑  “Russia authorizes use of ‘Sputnik Light,’ a one-shot Covid vaccine it says is 79% effective”. CNBC. (6 May 2021). https://www.cnbc.com/2021/05/06/sputnik-light-russia-authorizes-use-of-one-shot-covid-vaccine.html
↑  “Russia plans to start producing coronavirus vaccine in September” (英語).   Daily Sabah (2020年6月13日). 2020年8月10日閲覧。
↑  Ermakov A (August 11, 2020). “Вакцина от COVID-19 – в словах чиновников и документах разработчика” [Vaccine for COVID-19 - in the words of officials and developer documents] (ロシア語).   Fontanka.ru. 2020年9月21日閲覧。
↑  Tétrault-Farber G, Soldatkin V (11 August 2020). “Russia becomes first country to approve a COVID-19 vaccine, says Putin”. Reuters (Moscow). https://www.reuters.com/article/us-health-coronavirus-russia-vaccine-put/russia-becomes-first-country-to-approve-a-covid-19-vaccine-says-putin-idUSKCN25712U 11 August 2020閲覧。
↑  “About the vaccine to prevent the novel coronavirus infection COVID-19, "Gam-COVID-Vac", developed by the National Research Centre for Epidemiology and Microbiology named after academician N. F. Gamalei of the Ministry of Health of the Russian Federation”. Federal Service for Surveillance in Healthcare (August 12, 2020). 2020年8月18日閲覧。
↑  “Ministry of Health of the Russian Federation has issued a registration certification № ЛП-006395 dated August 11, 2020 for a vaccine to prevent the novel coronavirus infection COVID-19”.   Federal Service for Surveillance in Healthcare (2020年8月11日). 2020年9月21日閲覧。
↑  “Coronavirus: Putin says vaccine has been approved for use”. BBC. (11 August 2020). https://www.bbc.com/news/world-europe-53735718 11 August 2020閲覧。
↑  “Минздрав пообещал россиянам бесплатную вакцинацию от COVID-19” [Ministry of Health promised Russians free vaccination against COVID-19] (ロシア語). RBC.ru. 2020年10月23日閲覧。
↑  “В будущем вакцинация от COVID-19 будет проходить бесплатно” [In the future, vaccination against COVID-19 will be free of charge] (ロシア語). Russian Newspaper. 2020年10月23日閲覧。
1 2  “Минздрав зарегистрировал предельную отпускную цену на вакцину "Спутник V"” [The Ministry of Health registered the maximum selling price for the Sputnik V vaccine] (ロシア語).   RIA (December 5, 2020). 2020年9月21日閲覧。
↑  “Голикова назвала сроки выпуска первых партий вакцин НИЦ Гамалеи и "Вектора"” [Golikova announced the timing of the release of the first batches of vaccines of the Research Center of Gamaleya and "Vector"] (ロシア語).   Interfax (July 29, 2020). 2020年2月26日閲覧。
↑  “Запущено производство российской антикоронавирусной вакцины” [Production of Russian anti-coronavirus vaccine launched] (ロシア語).   Vesti (August 15, 2020). 2020年9月21日閲覧。
↑  Nebehay S (11 August 2020). “WHO says discussing new COVID-19 vaccine with Russia”. Reuters (Geneva). https://www.reuters.com/article/us-health-coronavirus-russia-vaccine-who/who-says-discussing-new-covid-19-vaccine-with-russia-idUSKCN2571BC 11 August 2020閲覧。
↑  “Russia has successfully fast tracked Covid-19 vaccine development, says India” (英語).  Mint (14 July 2020). 11 August 2020閲覧。
1 2  Brown C (2020年11月28日). “Russia says its COVID vaccine is 95% effective. So why is there still Western resistance to it?” (英語). www.cbc.ca. 2020年12月3日閲覧。
↑  Zamira Rahim. “Russia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19, interim trial results suggest”. CNN. 2021年2月9日閲覧。
↑  Jones, Ian; Roy, Polly (2021-02-02). “Sputnik V COVID-19 vaccine candidate appears safe and effective” (English). The Lancet 0. doi:10.1016/S0140-6736(21)00191-4. ISSN 0140-6736. PMID 33545098. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00191-4/abstract.
↑  Taylor, Adam; Johnson, Carolyn Y.. “Russian vaccine Sputnik V more than 90% effective in interim trial”. Washington Post. ISSN 0190-8286. https://www.washingtonpost.com/world/2021/02/02/sputnik-v-russia-lancet/ 2021年2月9日閲覧。
↑  Balakrishnan VS (1 October 2020). “The arrival of Sputnik V” (英語). The Lancet Infectious Diseases 20 (10):  1128. doi:10.1016/S1473-3099(20)30709-X. PMC 7511201. PMID 32979327. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30709-X/fulltext.
↑  Irfan U (11 December 2020). “Why staying cold is so important to a Covid-19 vaccine. The Moderna and Pfizer vaccines need to be stored at low temperatures. Are global health systems prepared?”.   Vox. 27 December 2020閲覧。
↑  Leger's Weekly Survey on Russian vaccine; saved copy on 5 38.com
↑  Ullah Z, Chernova A (6 September 2020). “Putin's vaccine meets opposition from frontline workers in Russia”. CNN. https://edition.cnn.com/2020/09/06/europe/russia-vaccine-putin-opposition-intl/ 6 September 2020閲覧。
↑  Mullin J, Malnick E (1 August 2020). “Britain unlikely to use Russia's 'untrustworthy' Covid vaccine”. The Telegraph.  オリジナルの19 August 2020時点におけるアーカイブ。. https://web.archive.org/web/20200819152533/https://www.telegraph.co.uk/news/2020/08/01/britain-unlikely-use-russias-untrustworthy-covid-vaccine/ 6 September 2020閲覧。
↑  “Covid: Russia begins vaccinations in Moscow”. BBC. (December 5, 2020). https://www.bbc.com/news/world-europe-55198166 2020年12月11日閲覧。
1 2  Soldatkin V, Oziel C (5 December 2020). “Moscow rolls out Sputnik V COVID-19 vaccine to most exposed groups”. Reuters. https://www.reuters.com/article/us-health-coronavirus-russia-vaccination/moscow-rolls-out-sputnik-v-covid-19-vaccine-to-most-exposed-groups-idUSKBN28F09O
↑  “Russia approves Sputnik V COVID-19 vaccine for people over 60: media”. Reuters. (26 December 2020). https://www.reuters.com/article/us-health-coronavirus-russia-vaccine/russia-approves-sputnik-v-covid-19-vaccine-for-people-over-60-media-idUSKBN29005A
↑  “Covid: Russia begins vaccinations in Moscow”. BBC News. (5 December 2020). https://www.bbc.com/news/world-europe-55198166
↑  “Moscow delivers Russia's Sputnik V coronavirus vaccine to clinics”. The Guardian. Reuters. (5 December 2020). https://www.theguardian.com/world/2020/dec/05/coronavirus-moscow-delivers-sputnik-v-vaccine-clinics-russia
↑  “Coronavirus: Russia rolls out COVID vaccination in Moscow”. Deutsche Welle. (5 December 2020). https://www.dw.com/en/coronavirus-russia-rolls-out-covid-vaccination-in-moscow/a-55831123
↑  Marrow A, Ostroukh A (2020年12月2日). “Putin orders Russia to begin a large-scale voluntary COVID-19 vaccination program next week” (英語). The Globe and Mail. https://www.theglobeandmail.com/world/article-putin-orders-russian-authorities-to-begin-mass-voluntary-covid-1// 2020年12月3日閲覧。
↑  “COVID-19: Moscow opens Sputnik V clinics – but 100,000 have already had it” (英語). Sky News. https://news.sky.com/story/covid-19-moscow-vaccine-launch-is-more-of-a-pr-event-100-000-have-already-had-it-12151854
↑  “Russia to vaccinate two million against COVID-19 in Dec - RDIF head to BBC”.   Reuters (December 4, 2020). 2020年9月21日閲覧。
↑  “About 6.9 mln doses of Sputnik V vaccine to enter circulation in Russia by end of February”.   TASS (December 10, 2020). 2020年9月21日閲覧。
↑  “Coronavirus in Russia: The Latest News”.   The Moscow Times (December 22, 2020). 2020年9月21日閲覧。
↑  “プーチン氏がワクチン接種　政府が発表、種類は明かさず”.  朝日新聞 (2021年3月24日). 2021年4月7日閲覧。
↑  “プーチン大統領が接種を受けたワクチンは？ 「スプートニクV」だったと公表”. スプートニク. (2021年6月30日). https://sptnkne.ws/GDDR 2021年7月8日閲覧。
↑  Rodgers J. “Facing Record COVID-19 Case Rise, Russia Rolls Out Sputnik V Vaccine” (英語). Forbes. https://www.forbes.com/sites/jamesrodgerseurope/2020/12/05/facing-record-covid-19-case-rise-russia-rolls-out-sputnik-v-vaccine/?sh=106eb262e197
↑  Arkhipov I, Kravchenko S (2 December 2020). “Putin Orders Start of Mass Covid-19 Shots Hours After U.K. News”. Bloomberg News. https://www.bloomberg.com/news/articles/2020-12-02/within-hours-of-u-k-putin-orders-start-of-mass-covid-19-shots
↑  Meyer H, Arkhipov I. “Russia Defends First Covid-19 Vaccine as Safe Amid Skepticism”. Bloomberg News. https://www.bloomberg.com/news/articles/2020-08-12/russia-defends-first-covid-19-vaccine-as-safe-amid-skepticism 12 August 2020閲覧。
↑  Litvinova D (24 November 2020). “Russian virus vaccine to cost less than $10 per dose abroad”. Associated Press. https://apnews.com/article/coronavirus-pandemic-russia-a781dda3087f453eef18c97082feedfb
↑  Osborn A, Nikolskaya P (2020年11月24日). “Russia's Sputnik COVID-19 vaccine to cost less than $20 per person internationally” (英語). The Globe and Mail. https://www.theglobeandmail.com/world/article-russias-sputnik-covid-19-vaccine-to-cost-less-than-20-per-person/ 2020年11月28日閲覧。
↑  Jaffe-Hoffman M (2020年11月12日). “Israel to receive Russia's 92% effective COVID vaccine” (英語). The Jerusalem Post. https://m.jpost.com/breaking-news/russias-sputnik-v-covid-19-vaccine-candidate-92-percent-effective-study-shows-648740/amp 2020年11月19日閲覧。
↑  “Buenos Aires Times | Argentina agrees to buy 25 million doses of Russia's Covid-19 vaccine”. www.batimes.com.ar. https://www.batimes.com.ar/news/argentina/argentina-agrees-to-buy-25-million-doses-of-russias-covid-19-vaccine.phtml
↑  “Argentina Approves Russian Vaccine With Plane Waiting in Moscow” (英語). Bloomberg.com (23 December 2020). 2020年2月26日閲覧。
↑  Boadle A (24 October 2020). “Second Brazilian company to produce Russia's Sputnik V COVID-19 vaccine”. Reuters. https://www.reuters.com/article/us-health-coronavirus-brazil-sputnik-idUSKBN2782VS
1 2  Ahmed A, Kumar AM (11 January 2021). “Russia's Sputnik V vaccine found safe in India mid-stage trial - Dr.Reddy's”. Reuters. https://www.reuters.com/article/health-coronavirus-india-vaccine-idUSL4N2JM2XA 26 January 2021閲覧。
↑  “More Countries Line Up for Russia's Sputnik V Coronavirus Vaccine”. The Moscow Times. (13 November 2020). https://www.themoscowtimes.com/2020/11/13/more-countries-line-up-for-russias-sputnik-v-coronavirus-vaccine-a72042
↑  “Argentina's president sits for Russian Covid jab” (英語). France 24. (21 January 2021). https://www.france24.com/en/live-news/20210121-argentina-s-president-sits-for-russian-covid-jab
↑  Centenera M (21 January 2021). “Alberto Fernández, primer presidente de América Latina en vacunarse contra la covid-19 (in Spanish)” (スペイン語). EL PAÍS. https://elpais.com/internacional/2021-01-21/alberto-fernandez-recibe-la-primera-dosis-de-la-vacuna-rusa-contra-la-covid-19.html
↑  “ロシア産ワクチン接種後に感染、アルゼンチン大統領にプーチン氏が「アフターケア」”.   読売新聞 (2021年4月6日). 2021年4月7日閲覧。
↑  “Belarus registers Sputnik V vaccine, in first outside Russia – RDIF”. Reuters. (21 December 2020). https://www.reuters.com/article/us-health-coronavirus-vaccine-belarus/belarus-registers-sputnik-v-vaccine-in-first-outside-russia-rdif-idINKBN28V0ZG 22 December 2020閲覧。
↑  Turak N (21 January 2021). “Russia's Sputnik vaccine gets its first approval in the EU, greenlight from UAE amid ongoing trials” (英語). CNBC. https://www.cnbc.com/2021/01/21/russias-sputnik-vaccine-gets-its-first-approval-in-the-eu-uae.html
↑  “Coronavirus: Hungary first in EU to approve Russian vaccine”. BBC News. (21 January 2021). https://www.bbc.com/news/world-europe-55747623
↑  Walker S (21 January 2021). “Hungary breaks ranks with EU to license Russian vaccine”. The Guardian. https://www.theguardian.com/world/2021/jan/21/hungary-breaks-ranks-with-eu-to-license-russian-vaccine-sputnik-v
↑  “Hungary Becomes First in EU to Approve Russian Covid Vaccine” (英語). Bloomberg.com. (21 January 2021). https://www.bloomberg.com/news/articles/2021-01-21/hungary-becomes-first-in-eu-to-approve-russia-s-covid-vaccine
↑  “COVID: Hungary fast-tracks Russian vaccine with EU approval in the works | DW | 21.01.2021”. DW.COM. https://www.dw.com/en/covid-hungary-fast-tracks-russian-vaccine-with-eu-approval-in-the-works/a-56306084#:~:text=Hungary%20has%20become%20the%20first,Russia's%20Sputnik%20V%20coronavirus%20vaccine.&text=Hungary%20approved%20the%20vaccine%20independently,European%20Medicines%20Agency%20(EMA).
↑  “Russia files for Sputnik vaccine registration in EU”. Euractiv.com. (20 January 2021). https://www.euractiv.com/section/health-consumers/news/russia-files-for-sputnik-vaccine-registration-in-eu/
↑  “Clarification on Sputnik V vaccine in the EU approval process”.   European Medicines Agency (10 February 2021). 2020年2月26日閲覧。
↑  “Da la Cofepris autorización para que la vacuna Sputnik V se aplique en México” (スペイン語). Diario de Yucatán. (2 February 2021). https://www.yucatan.com.mx/mexico/agilizan-la-autorizacion-para-que-la-vacuna-sputnik-v-se-aplique-en-mexico
↑  “Iran approves Russia's Sputnik V COVID-19 vaccine” (英語). Al Jazeera. https://www.aljazeera.com/news/2021/1/26/iran-approves-russias-sputnik-v-covid-19-vaccine
↑  Reuters Staff (26 January 2021). “Iran approves Russian coronavirus vaccine Sputnik V” (英語). Reuters. https://www.reuters.com/article/us-health-coronavirus-russia-iran/iran-approves-russian-coronavirus-vaccine-sputnik-v-idUSKBN29V1A8
2020年8月11日、プーチン大統領はビデオ会議で政府関係者と会談し、条件付き登録されたCOVID-19ワクチンを発表した。
ワクチンを手にするモスクワの医療従事者
北方艦隊の軍人および民間専門家に対するGam-COVID-Vac（スプートニクV）薬剤の第2成分によるワクチン接種。
濃い緑色は、数百万のスプートニクVを発注した国。薄緑色は、ワクチンの入手に関心を示している国、または試験を既に試験を行っている国である。